Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma III: Clinical Manifestations

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Respiratory research·2026

Same author

An early window into immune developmental trajectory of asthma.

American journal of respiratory and critical care medicine·2026

Same author

Whole Genome Sequence Analysis of Weight Loss in 16 972 Participants With COPD Reveals Novel Risk Loci in DRAIC and RFX3.

Journal of cachexia, sarcopenia and muscle·2026

Same author

Stability and age-specific patterns of rhinovirus circulation in children observed over 3 decades.

The Journal of allergy and clinical immunology·2026

Same author

A Quantitative Lung Mucin Score to Identify Chronic Bronchitis.

NEJM evidence·2026

Same author

Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota links.

BMJ open respiratory research·2025

Search research articles

Related Experiment Video

Updated: May 5, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Clinical heterogeneity in the severe asthma research program.

Wendy C Moore¹, Anne M Fitzpatrick, Xingnan Li

¹1 Wake Forest University School of Medicine, Center for Human Genomics, Winston Salem, North Carolina; and.

Annals of the American Thoracic Society

|December 10, 2013

Summary

The Severe Asthma Research Program (SARP) characterized 1,644 asthma patients, revealing diverse phenotypes. Understanding these asthma subtypes is crucial for tailoring treatments, especially for severe cases on the edge of classifications.

More Related Videos

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

Related Experiment Videos

Last Updated: May 5, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

Area of Science:

Pulmonology and Respiratory Medicine
Clinical Research
Asthma Pathophysiology

Background:

The National Heart, Lung, and Blood Institute established the Severe Asthma Research Program (SARP).
SARP is unique as it is not a clinical trials network and includes both adult and pediatric asthma patients.
Over 10 years, SARP comprehensively characterized 1,644 asthma patients, including 583 severe asthma cases and 300 children.

Purpose of the Study:

To investigate asthma heterogeneity using a diverse patient cohort.
To describe multiple asthma phenotypes using biased and unbiased approaches.
To improve the understanding of asthma heterogeneity and inform evidence-based classification of disease severity.

Main Methods:

Comprehensive characterization of 1,644 asthma patients over 10 years.
Inclusion of adult and pediatric populations, including severe asthma cases.
Application of biased and unbiased approaches for phenotypic analysis and cluster analysis.

Main Results:

Multiple asthma phenotypes were identified within the SARP cohort.
Phenotypic analyses enhanced the understanding of asthma heterogeneity.
Cluster analysis revealed patients on the 'edge' of phenotypes with differing lung function, suggesting varied pathophysiologic mechanisms.

Conclusions:

Asthma phenotypes provide a framework for classifying disease severity and guiding therapy.
Phenotypic classification has limitations due to inherent patient heterogeneity.
Patients on the 'edge' of phenotypes may have distinct pathophysiologic mechanisms requiring tailored therapeutic strategies, particularly in severe asthma.